Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value
$109.21M
Total Bought
$34.44M
Total Sold
$8.24M
Net Transaction
+$26.20M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
ICOSAVAX INC3,510,2283,510,228027,20455,32150.66%+28,117
KORRO BIO INC(KRRO)0368,085+368,085017,64216.15%+17,642
TOURMALINE BIO INC0641,691+641,691016,79915.38%+16,799
HILLEVAX INC558,923558,92307,5188,9718.21%+1,453
JASPER THERAPEUTICS INC(JSPR)8,519,6488,519,64805,9646,7226.16%+758
KEZAR LIFE SCIENCES INC828,711828,71109867850.72%-201
ELEVATION ONCOLOGY INC2,370,1422,370,14201,5701,2731.17%-298
TALARIS THERAPEUTICS INC2,932,6060-2,932,6068,2410—-8,241
VENTYX BIOSCIENCES INC686,370686,370023,8381,6951.55%-22,142
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q4 2023 | TickerTrail